Search hospitals > California > Santa Rosa
Providence Medical Foundation - Santa Rosa
Claim this profileSanta Rosa, California 95403
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
49 reported clinical trials
8 medical researchers
Summary
Providence Medical Foundation - Santa Rosa is a medical facility located in Santa Rosa, California. This center is recognized for care of Cancer, Breast Cancer, Tumors, Adenocarcinoma, Lung Cancer and other specialties. Providence Medical Foundation - Santa Rosa is involved with conducting 49 clinical trials across 199 conditions. There are 8 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Alison K. ConlinProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
179 drugs studied
Charles W. DrescherProvidence Portland Medical Center7 years of reported clinical research
Expert in Cancer
Studies Tumors
47 reported clinical trials
96 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Cancer
Studies Recurrence
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Studies Adenocarcinoma
26 reported clinical trials
63 drugs studied
Clinical Trials running at Providence Medical Foundation - Santa Rosa
Breast Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Cancer
Ovarian Tumors
Pancreatic Cancer
Tumors
Gallbladder Cancer
Colorectal Cancer
Lung Cancer
ARV-471
for Breast Cancer
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
Recruiting2 awards Phase 35 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Providence Medical Foundation - Santa Rosa?
Providence Medical Foundation - Santa Rosa is a medical facility located in Santa Rosa, California. This center is recognized for care of Cancer, Breast Cancer, Tumors, Adenocarcinoma, Lung Cancer and other specialties. Providence Medical Foundation - Santa Rosa is involved with conducting 49 clinical trials across 199 conditions. There are 8 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.